Related Experiment Video
Updated: Apr 18, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
[Long noncoding RNAs in prostate cancer]
Zhang-qun Ye1, Tao Wang, Wen Song
1Department of Urology, Tongji Hospital, Huazhong University of Science and Technology, Hubei, China. zhangqun_ye@163.com
Abstract:
Long non-coding RNAs (lncRNAs) are a group of RNA molecules which are longer than 200 nucleotides. They do not have functional open reading frames and cannot encode proteins. Recent studies have demonstrated that lncRNAs are widely involved in the regulation of gene expression network at epigenetic, transcriptional and post-transcriptional levels, which may affect the growth, proliferation, differentiation, metabolism, apoptosis and other important physiological processes of cells. The abnormal expression of lncRNAs is closely associated with the development, invasion, metastasis and prognosis of tumors. The development of prostate cancer is a multi-factor and multi-step process, in which abnormal gene expression may play an important role. This review focuses on the recent progress in the studies on the role of lncRNAs in prostate cancer, aiming for some new clues to the clinical prevention, diagnosis and treatment of this malignancy.
Insights
Long non-coding RNAs (lncRNAs) regulate gene expression and are implicated in cancer. This review explores lncRNA roles in prostate cancer, offering insights for clinical applications.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (lncRNAs) are RNA molecules >200 nucleotides without protein-coding potential.
- lncRNAs regulate gene expression at epigenetic, transcriptional, and post-transcriptional levels.
- Aberrant lncRNA expression is linked to tumor development, invasion, metastasis, and prognosis.
Purpose of the Study:
- To review recent advancements in understanding lncRNA functions in prostate cancer.
- To identify potential new avenues for clinical prevention, diagnosis, and treatment of prostate cancer.
Main Methods:
- Literature review of studies on lncRNAs and prostate cancer.
- Analysis of lncRNA involvement in prostate cancer's multi-step development process.
Main Results:
- lncRNAs significantly impact cellular processes like growth, proliferation, differentiation, metabolism, and apoptosis.
- Abnormal lncRNA expression is a key factor in prostate cancer progression.
- lncRNAs offer potential as biomarkers and therapeutic targets in prostate cancer.
Conclusions:
- lncRNAs play a critical role in the pathogenesis of prostate cancer.
- Further research into lncRNAs may yield novel strategies for prostate cancer management.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Non-LTR Retrotransposons
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...

